Nuvectis Pharma Provides Final Clinical Data Update From The NXP800 Phase 1B Study In Ovarian Cancer And Reports Completion Of The NXP900 Phase 1A Dose Escalation Study
ReutersJul 31, 2025 12:49 PM
July 31 (Reuters) - Nuvectis Pharma Inc NVCT.O:
NUVECTIS PHARMA PROVIDES FINAL CLINICAL DATA UPDATE FROM THE NXP800 PHASE 1B STUDY IN OVARIAN CANCER AND REPORTS COMPLETION OF THE NXP900 PHASE 1A DOSE ESCALATION STUDY
NUVECTIS PHARMA INC - NXP800 PHASE 1B STUDY SHOWS 2 PARTIAL RESPONSES, 3 STABLE DISEASES
NUVECTIS PHARMA INC - NXP900 COMPLETES PHASE 1A STUDY, PHASE 1B TO START SOON
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Amazon Q2 FY2025 Earnings Review: Robust Cloud and AI Growth Coupled with Retail Tariff Challenges
TradingKey - Amazon.com, Inc. (NASDAQ: AMZN) released its Q2 FY2025 earnings on July 31, 2025, after market close, delivering results that surpassed expectations, driven by robust growth in AWS, advertising, and retail segments.TradingKey
25 minutes ago
Apple Q3 FY2025 Earnings Review: Strong iPhone Performance and AI Momentum Amid Tariff Challenges
TradingKey - Apple Inc. (NASDAQ: AAPL) released its Q3 FY2025 earnings on July 31, 2025, after market close, delivering results that surpassed expectations, driven by robust iPhone sales and strong Services growth. Despite a slight dip in initial after-hours trading, Apple’s stock rose 2%...TradingKey
2 hours ago
What Is Binance Coin (BNB), and Can It Really Hit $2,775 by 2028?
BNB is the native token of Binance, the world’s largest crypto exchange. Launched in 2017 via an ICO, BNB started as an ERC-20 token on Ethereum before migrating to BNB Chain, which includes both the Binance Smart Chain (BSC) and Binance Chain.TradingKey
5 hours ago
Microsoft 4Q25 Earnings Comment: Azure is Leading the Parade
TradingKey - Microsoft will release its earnings for the second quarter of the fiscal 2025 on July 30th after the market closed:- 4Q25 Earnings per share: $3.65 vs $3.37 estimate (+24% y/y) - 4Q25 Revenue: $76.44 vs $73.93bn estimate (+19% y/y)TradingKey
Thu, Jul 31
What to Expect From Meta Q2 Earnings: AI Push, Ad Strength — But Can Profitability Hold?
TradingKey - Meta Platforms (META), the parent company of Facebook, Instagram, and WhatsApp, will release its Q2 2025 earnings after the U.S. market close on Wednesday, July 30. After nine consecutive quarters of beating expectations, analysts expect another strong performance — driven by AI-poweredTradingKey
Tue, Jul 29
